Legislative Initiatives and Review of Abuse-Deterrent Opioid Formulations

被引:0
|
作者
Ng, Kimberly Erin [1 ]
Ahmed, Ebtesam [1 ]
Saad, Maha [1 ]
机构
[1] St Johns Univ, Coll Pharm & Hlth Sci, Queens, NY 11439 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioid analgesics are the mainstay treatment of moderate-to-severe pain. However, opioids carry a risk of misuse, abuse, and death, and recently have become a public health challenge. In response to the steady increase in opioid abuse, pressure has been growing on pharmaceutical companies to develop prescription opioid formulations that help deter abuse while remaining readily accessible for pain management. This article discusses some of the novel abuse-deterrent formulation methods, including aversion, physical barrier, and agonist-antagonist. It also addresses some of the legislative initiatives and the role of pharmacists in providing education to health care professionals and patients as well as increasing their awareness of prescription opioid misuse and abuse.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Abuse-Deterrent Opioid Formulations
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1744 - 1745
  • [2] Abuse-deterrent Opioid Formulations
    Litman, Ronald S.
    Pagan, Olivia H.
    Cicero, Theodore J.
    [J]. ANESTHESIOLOGY, 2018, 128 (05) : 1015 - 1026
  • [3] Abuse-Deterrent Opioid Formulations
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1476): : 119 - 121
  • [4] Abuse-Deterrent Opioid Formulations #329
    O'Neill, Ryann
    Lor, Kimberly
    Pruskowski, Jennifer
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (06) : 676 - 678
  • [5] Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access
    Webster, Lynn
    Gudin, Jeffrey
    [J]. JOURNAL OF PAIN RESEARCH, 2024, 17 : 1989 - 2000
  • [6] Abuse-deterrent opioid formulations: Are they a pipe dream?
    Katz N.
    [J]. Current Rheumatology Reports, 2008, 10 (1) : 11 - 18
  • [7] The role of abuse-deterrent formulations in countering opioid misuse and abuse
    Nguyen, V.
    Raffa, R. B.
    Taylor, R.
    Pergolizzi, J. V., Jr.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) : 629 - 634
  • [8] Are abuse-deterrent opioid formulations all they are crushed up to be?
    Nelson, Lewis S.
    [J]. ADDICTION, 2019, 114 (03) : 401 - 402
  • [9] Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations
    Walter, Carmen
    Knothe, Claudia
    Loetsch, Joern
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (07) : 751 - 767
  • [10] Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations
    Carmen Walter
    Claudia Knothe
    Jörn Lötsch
    [J]. Clinical Pharmacokinetics, 2016, 55 : 751 - 767